Several exposures and experiences have been associated with younger age childhood leukemias, typically in children diagnosed less than 2 years of age. These include maternal alcohol consumption during pregnancy, maternal pesticide and solvent exposure during pregnancy, and infant birthweight in excess of 4000 grams. However, a diagnosis of less than 2 years of age is an inadequate characterization of infant leukemia. There are marked differences in clinical behavior and frequency of a specific genetic abnormality in cases diagnosed less than 1 year of age compared to cases diagnosed at older ages. Approximately 60 percent of infants with acute myeloid leukemia (AML) and 80 percent of infants with acute lymphoblastic leukemia (ALL) have a molecular abnormality in their leukemia cells involving the gene, MLL, at chromosome band 11q23; the frequency of this abnormality drops precipitously after 1 year of age. There is substantial evidence that these MLL abnormalities occur during pregnancy. Thus, infants with leukemia may be a highly informative subgroup for the identification of possible environmental exposures in utero that act as initiators. This case-control study will include infants with ALL and AML and randomly selected, individually-matched controls. This study is designed to explore the following in this unique patient population (1) maternal exposure to DNA topoisomerase II inhibitors during pregnancy is associated with infant AML that manifests MLL abnormalities; (2) mothers of infant cases are more likely to have exposures to pesticides and solvents during pregnancy; (3) in utero exposure to alcohol is associated with an increased risk of infant AML; (4) mothers of female cases are more likely to have a reproductive history that included fetal loss prior to the pregnancy of the index child; (5) infant cases, particularly ALL, will weigh more than infant controls; and (6) there will be a higher frequency of MLL abnormalities among female infants with leukemia compared with male infants with leukemia. This study will utilize the unique resources available through the Children's Cancer Group, and include ascertainment of cases over a six-year period (Jan 1, 1996-Dec 31, 2001). Included in this study will be the integration of molecular data documenting the presence or absence of an MLL abnormality. The overall sample size includes 250 matched sets (2 controls per case), which will provide sufficient statistical power to address the hypothesis being investigated.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA079940-04
Application #
6489176
Study Section
Special Emphasis Panel (ZRG4-EDC-2 (02))
Program Officer
Verma, Mukesh
Project Start
1999-02-09
Project End
2003-12-31
Budget Start
2002-01-01
Budget End
2003-12-31
Support Year
4
Fiscal Year
2002
Total Cost
$388,882
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Type
Schools of Medicine
DUNS #
168559177
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Marcotte, Erin L; Richardson, Michaela R; Roesler, Michelle A et al. (2018) Cesarean Delivery and Risk of Infant Leukemia: A Report from the Children's Oncology Group. Cancer Epidemiol Biomarkers Prev 27:473-478
Valentine, M C; Linabery, A M; Chasnoff, S et al. (2014) Excess congenital non-synonymous variation in leukemia-associated genes in MLL- infant leukemia: a Children's Oncology Group report. Leukemia 28:1235-41
Poynter, Jenny N; Ross, Julie A; Hooten, Anthony J et al. (2013) Predictors of mother and child DNA yields in buccal cell samples collected in pediatric cancer epidemiologic studies: a report from the Children's Oncology group. BMC Genet 14:69
Ross, Julie A; Linabery, Amy M; Blommer, Crystal N et al. (2013) Genetic variants modify susceptibility to leukemia in infants: a Children's Oncology Group report. Pediatr Blood Cancer 60:31-4
Sam, Thien N; Kersey, John H; Linabery, Amy M et al. (2012) MLL gene rearrangements in infant leukemia vary with age at diagnosis and selected demographic factors: a Children's Oncology Group (COG) study. Pediatr Blood Cancer 58:836-9
Ognjanovic, S; Blair, C; Spector, L G et al. (2011) Analgesic use during pregnancy and risk of infant leukaemia: a Children's Oncology Group study. Br J Cancer 104:532-6
Slater, Megan E; Linabery, Amy M; Blair, Cindy K et al. (2011) Maternal prenatal cigarette, alcohol and illicit drug use and risk of infant leukaemia: a report from the Children's Oncology Group. Paediatr Perinat Epidemiol 25:559-65
Slater, Megan E; Linabery, Amy M; Spector, Logan G et al. (2011) Maternal exposure to household chemicals and risk of infant leukemia: a report from the Children's Oncology Group. Cancer Causes Control 22:1197-204
Jurek, Anne M; Greenland, Sander; Spector, Logan G et al. (2011) Self-report versus medical record - perinatal factors in a study of infant leukaemia: a study from the Children's Oncology Group. Paediatr Perinat Epidemiol 25:540-8
Puumala, Susan E; Spector, Logan G; Wall, Melanie M et al. (2010) Infant leukemia and parental infertility or its treatment: a Children's Oncology Group report. Hum Reprod 25:1561-8

Showing the most recent 10 out of 25 publications